Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2005
12/01/2005WO2002092012A3 Compositions and methods for treating tumors bearing hmfg and cea antigens
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267208 Nordihydroguaiartic derivatives for use in treatment of tumors
12/01/2005US20050267201 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/01/2005US20050267200 Heteroaromate OSC inhibitors
12/01/2005US20050267196 Reducing tumor necrosis factor; phosphodiesterase inhibitor; anticancer agents; antidepressants; antiinflammatory agents; skin dsorders; antidepressants
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267189 Celecoxib compositions
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267183 Selective estrogen receptor modulators
12/01/2005US20050267179 Novel thioether derivatives
12/01/2005US20050267133 Pyrazolopyrimidines as kinase inhibitors
12/01/2005US20050267129 Dipeptide nitrile cathepsin K inhibitors
12/01/2005US20050267127 Guanidino phenylalanin compounds used as urokinase inhibitors
12/01/2005US20050267125 High drug load tablet
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
12/01/2005US20050267114 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
12/01/2005US20050267110 Propane-1, 3-dione derivative
12/01/2005US20050267079 Tetracycline derivatives and methods of use thereof
12/01/2005US20050267069 Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
12/01/2005US20050267066 Pharmaceutical composition comprising a CDK inhibitor and gemcitabine
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267062 Endothelial growth factors; antiischemic agents; neovascularization
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050267048 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
12/01/2005US20050267044 Novel compounds and compositions as cathepsin S inhibitors
12/01/2005US20050267041 Tetrapeptide derivative crystals
12/01/2005US20050267024 Polypeptide, cancer therapy, neovascularization defects, retinopathies, arthritis and psoraisis
12/01/2005US20050267022 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
12/01/2005US20050267020 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
12/01/2005US20050267016 Therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle
12/01/2005US20050267012 Contacting with Bacillus anthracis lethal factor
12/01/2005US20050266549 Molecular switch for regulating mammalian gene expression
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266486 Methods for treating obesity by inhibiting expression of obese gene product receptor variant
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266483 Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
12/01/2005US20050266437 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
12/01/2005US20050266107 Administering mixture of flavopereirine and alstonine for preventing prostate cancer and/or reducing PSA levels and/or alleviating the symptoms of BPH (Benign Prostatic Hyperplasia) or PIN (prostatic intraepithelial neoplasia)
12/01/2005US20050266020 Modular transport systems for molecular substances and production and use thereof
12/01/2005US20050266012 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same
12/01/2005US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies
12/01/2005US20050265987 Sulfatases and methods of use thereof
12/01/2005US20050265976 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
12/01/2005US20050265971 Agent for treatment of breast cancer and pancreatic cancer comprising herpes simplex virus mutant
12/01/2005US20050265969 Therapeutic chemokine receptor antagonists
12/01/2005US20050265965 Modified cytokines for use in cancer therapy
12/01/2005US20050262765 Floral packaging material having great masters prints thereon
12/01/2005DE102004022383A1 New pyridopyrazine derivatives are modulators of kinase activity, useful for the treatment of diseases associated with abnormal cellular signaling, e.g. tumors
12/01/2005DE102004021658A1 Anticancer product comprises 2-methylthiazolidine-2,4-dicarboxylic acid and an antiangiogenic, cytotoxic or cytostatic compound
12/01/2005DE102004021637A1 Dihydrobenzothiophene Dihydrobenzothiophene
12/01/2005CA2826538A1 3-triazolyl-galactoside inhibitors of galectins
12/01/2005CA2730540A1 Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
12/01/2005CA2578549A1 Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
12/01/2005CA2567700A1 3-triazolyl-galactoside inhibitors of galectins
12/01/2005CA2567694A1 Novel galactoside inhibitors of galectins
12/01/2005CA2567404A1 Cyclopenta[b]benzofuran derivatives and the utilization thereof
12/01/2005CA2567228A1 Thiophene heteroaryl amines
12/01/2005CA2566745A1 Methods of treating cancer using il-21 and monoclonal antibody therapy
12/01/2005CA2566444A1 Prodrugs of pyrrolylpyrimidine erk protein kinase inhibitors
12/01/2005CA2566363A1 High affinity ny-eso t cell receptor
12/01/2005CA2565519A1 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005CA2564538A1 Compositions and methods for modulating signaling mediated by igf-1 receptor and erbb receptors
12/01/2005CA2564215A1 Substituted quinoline derivatives as mitotic kinesin inhibitors
12/01/2005CA2563666A1 Differentially expressed claudin-18 variants in tumors and use thereof
12/01/2005CA2562990A1 Mucinous glycoprotein (muc-1) vaccine
11/2005
11/30/2005EP1600445A1 Medicinal composition
11/30/2005EP1600161A2 Processes for preparing 13-deoxyanthracycline derivatives as anticancer of low cardio toxicity
11/30/2005EP1600152A1 Use of LIF in cosmetics and dermatology
11/30/2005EP1599600A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2)
11/30/2005EP1599573A2 Model for studying the role of genes in tumor resistance to chemotherapy
11/30/2005EP1599572A2 Compositions and methods for cancer immunotherapy
11/30/2005EP1599503A2 Endothelial cell specific antibodies and uses thereof
11/30/2005EP1599501A2 Modulation of the poliovirus receptor function
11/30/2005EP1599493A1 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
11/30/2005EP1599491A1 Bifunctional heterocyclic compounds and methods of making and using the same
11/30/2005EP1599485A2 Podophyllotoxin derivatives as antitumor agents
11/30/2005EP1599484A2 Process for the preparation of hexacyclic camptothecin derivatives
11/30/2005EP1599482A1 Pyrazolo 1,5-a pyrimidine derivatives
11/30/2005EP1599467A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/30/2005EP1599466A2 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders
11/30/2005EP1599464A2 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
11/30/2005EP1599462A2 Process of preparing imatinib
11/30/2005EP1599449A2 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
11/30/2005EP1599258A1 Fumed silica embolic compositions
11/30/2005EP1599228A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/30/2005EP1599226A1 A method of diagnosis and treatment
11/30/2005EP1599218A1 Clostridial neurotoxins for treating uterine disorders
11/30/2005EP1599202A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/30/2005EP1599200A2 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
11/30/2005EP1599196A2 Combination therapies for the treatment of cancer
11/30/2005EP1599165A2 The use of gcc ligands
11/30/2005EP1432708B1 Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity
11/30/2005EP1392702B1 Compounds and methods for inhibiting mrp1
11/30/2005EP1380295A4 Photosensitiser and method for production thereof
11/30/2005EP1317483B1 Variants of allergenic proteins of the group 2 of dermatophagoides
11/30/2005EP1301605B1 Nk cells activating receptors and their therapeutic and diagnostic uses
11/30/2005EP1278521B1 N-heterocyclic substituted salicylates for the treatment of cancer
1 ... 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 ... 2211